- Home
- FSLR vs NBIX Comparison
FSLR vs NBIX Comparison
Compare FSLR & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSLR
- NBIX
- Stock Information
- Founded
- FSLR 1999
- NBIX 1992
- Country
- FSLR United States
- NBIX United States
- Employees
- FSLR N/A
- NBIX N/A
- Industry
- FSLR Semiconductors
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FSLR Technology
- NBIX Health Care
- Exchange
- FSLR Nasdaq
- NBIX Nasdaq
- Market Cap
- FSLR 13.1B
- NBIX 12.4B
- IPO Year
- FSLR 2006
- NBIX 1996
- Fundamental
- Price
- FSLR $163.19
- NBIX $134.33
- Analyst Decision
- FSLR Strong Buy
- NBIX Strong Buy
- Analyst Count
- FSLR 29
- NBIX 21
- Target Price
- FSLR $232.30
- NBIX $165.14
- AVG Volume (30 Days)
- FSLR 5.4M
- NBIX 821.3K
- Earning Date
- FSLR 07-29-2025
- NBIX 07-30-2025
- Dividend Yield
- FSLR N/A
- NBIX N/A
- EPS Growth
- FSLR 23.43
- NBIX N/A
- EPS
- FSLR 11.77
- NBIX 2.96
- Revenue
- FSLR $4,256,749,000.00
- NBIX $2,412,600,000.00
- Revenue This Year
- FSLR $22.39
- NBIX $16.29
- Revenue Next Year
- FSLR $21.13
- NBIX $15.08
- P/E Ratio
- FSLR $13.80
- NBIX $45.11
- Revenue Growth
- FSLR 19.42
- NBIX 21.73
- 52 Week Low
- FSLR $116.56
- NBIX $84.23
- 52 Week High
- FSLR $262.72
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- FSLR 50.95
- NBIX 70.92
- Support Level
- FSLR $163.19
- NBIX $127.03
- Resistance Level
- FSLR $168.48
- NBIX $135.94
- Average True Range (ATR)
- FSLR 7.85
- NBIX 2.85
- MACD
- FSLR 0.24
- NBIX 0.47
- Stochastic Oscillator
- FSLR 47.62
- NBIX 87.52
About FSLR First Solar Inc.
First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and India.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.